Literature DB >> 25366258

Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings.

Elizabeth I Pierpont1, Erica Tworog-Dube, Amy E Roberts.   

Abstract

AIM: Emerging research indicates that gene mutations within the RAS-MAPK signaling cascade, which cause Noonan syndrome and related disorders, affect neurophysiologic activity in brain regions underlying attention and executive functions. The present study examined whether children with Noonan syndrome are at heightened risk for symptoms of attention-deficit-hyperactivity disorder (ADHD) and executive dysfunction relative to an unaffected sibling comparison group, and investigated three key aspects of behavioral attention: auditory attention, sustained attention, and response inhibition.
METHOD: Children and adolescents with Noonan syndrome (n=32, 17 males, 15 females, mean age 11y 3mo, SD 3y) and their unaffected siblings (n=16, eight males, eight females, mean age 11y, SD 3y 6mo) were administered standardized tests of intellectual functioning and clinic-based measures of behavioral attention. Parent ratings of ADHD symptoms, executive functioning, and behavior were also obtained.
RESULTS: Children with Noonan syndrome demonstrated higher rates of past ADHD diagnosis, as well as reduced performance compared with unaffected siblings on behavioral attention measures. Parent-rated functional impairments in attention, social skills, working memory, and self-monitoring were more prevalent in the Noonan syndrome group. The relationship between attention regulation skills (sustained attention and inhibitory control) and intellectual test performance was significantly stronger in the Noonan syndrome group than the comparison group.
INTERPRETATION: Clinical screening/evaluation for ADHD and executive dysfunction in Noonan syndrome is recommended to facilitate appropriate intervention and to address functional impact on daily life activities.
© 2014 Mac Keith Press.

Entities:  

Mesh:

Year:  2014        PMID: 25366258     DOI: 10.1111/dmcn.12621

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  13 in total

Review 1.  Genetic contribution to neurodevelopmental outcomes in congenital heart disease: are some patients predetermined to have developmental delay?

Authors:  Caitlin K Rollins; Jane W Newburger; Amy E Roberts
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

2.  PTPN11 Gain-of-Function Mutations Affect the Developing Human Brain, Memory, and Attention.

Authors:  Emily M Johnson; Alexandra D Ishak; Paige E Naylor; David A Stevenson; Allan L Reiss; Tamar Green
Journal:  Cereb Cortex       Date:  2019-07-05       Impact factor: 5.357

3.  Clinical and molecular spectra of BRAF-associated RASopathy.

Authors:  Yena Lee; Yunha Choi; Go Hun Seo; Gu-Hwan Kim; In Hee Choi; Changwon Keum; Jung Min Ko; Chong Kun Cheon; Jihyun Jeon; Jin-Ho Choi; Han-Wook Yoo; Beom Hee Lee
Journal:  J Hum Genet       Date:  2020-10-10       Impact factor: 3.172

4.  Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway.

Authors:  Jennifer L Bruno; Sharon B Shrestha; Allan L Reiss; Manish Saggar; Tamar Green
Journal:  Mol Psychiatry       Date:  2022-01-28       Impact factor: 13.437

5.  Intellectual development in Noonan syndrome: a longitudinal study.

Authors:  Renée L Roelofs; Nikki Janssen; Ellen Wingbermühle; Roy P C Kessels; Jos I M Egger
Journal:  Brain Behav       Date:  2016-05-03       Impact factor: 2.708

Review 6.  Attention deficit hyperactivity disorder (ADHD) in phenotypically similar neurogenetic conditions: Turner syndrome and the RASopathies.

Authors:  Tamar Green; Paige E Naylor; William Davies
Journal:  J Neurodev Disord       Date:  2017-07-10       Impact factor: 4.025

7.  Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.

Authors:  Elizabeth I Pierpont; Rebekah L Hudock; Allison M Foy; Margaret Semrud-Clikeman; Mary Ella Pierpont; Susan A Berry; Ryan Shanley; Nathan Rubin; Katherine Sommer; Christopher L Moertel
Journal:  J Neurodev Disord       Date:  2018-06-18       Impact factor: 4.025

8.  Defining language disorders in children and adolescents with Noonan Syndrome.

Authors:  Giulia Lazzaro; Cristina Caciolo; Deny Menghini; Francesca Cumbo; Maria C Digilio; Rossella Capolino; Giuseppe Zampino; Marco Tartaglia; Stefano Vicari; Paolo Alfieri
Journal:  Mol Genet Genomic Med       Date:  2020-02-14       Impact factor: 2.183

9.  PTPN11 Mutations in the Ras-MAPK Signaling Pathway Affect Human White Matter Microstructure.

Authors:  Mustafa Fattah; Mira M Raman; Allan L Reiss; Tamar Green
Journal:  Cereb Cortex       Date:  2021-02-05       Impact factor: 5.357

10.  Pragmatic language impairment in children with Noonan syndrome.

Authors:  Magnhild Selås; Wenche Andersen Helland
Journal:  Clin Linguist Phon       Date:  2016-06-27       Impact factor: 1.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.